Ohcanbohtosat - Schmidt, Darja

  • Čájehuvvo 1 - 6 / 6
Aiddostahte ozu
  1. 1
    Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity

    Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity Dahkki Schmidt, Darja, Müller, Stefan

    Almmustuhtton 2002
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    LB11. A Single Dose of the MVA-BN Smallpox Vaccine Induces an Early Protective Antibody Response Similar to a Traditional Replicating Vaccine and Is Suitable for Emergency Scenarios

    LB11. A Single Dose of the MVA-BN Smallpox Vaccine Induces an Early Protective Antibody Response Similar to a Traditional Replicating Vaccine and Is Suitable for Emergency Scenario... Dahkki Maclennan, Jane, Weidenthaler, Heinz, Pittman, Phillip, Schmidt, Darja, Chaplin, Paul

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Down-Regulation of c-Fos/c-Jun AP-1 Dimer Activity by Sumoylation

    Down-Regulation of c-Fos/c-Jun AP-1 Dimer Activity by Sumoylation Dahkki Bossis, Guillaume, Malnou, Cécile E., Farras, Rosa, Andermarcher, Elisabetta, Hipskind, Robert, Rodriguez, Manuel, Schmidt, Darja, Muller, Stefan, Jariel-Encontre, Isabelle, Piechaczyk, Marc

    Almmustuhtton 2005
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: A randomised, double blind, placebo controlled phase III trial

    Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: A randomised, double blind, placebo controlled phase III trial Dahkki Overton, Edgar Turner, Lawrence, Steven J., Wagner, Eva, Nopora, Katrin, Rösch, Siegfried, Young, Philip, Schmidt, Darja, Kreusel, Christian, De Carli, Sonja, Meyer, Thomas P., Weidenthaler, Heinz, Samy, Nathaly, Chaplin, Paul

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18–40 Year Old Subjects with Diagnosed Atopic Dermatitis

    A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18–40 Year Old Subjects with Diagnosed Atopic Derma... Dahkki Greenberg, Richard N, Hurley, Yadira, Dinh, Dinh V., Mraz, Serena, Vera, Javier Gomez, von Bredow, Dorothea, von Krempelhuber, Alfred, Roesch, Siegfried, Virgin, Garth, Arndtz-Wiedemann, Nathaly, Meyer, Thomas Peter, Schmidt, Darja, Nichols, Richard, Young, Philip, Chaplin, Paul

    Almmustuhtton 2015
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects

    A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old S... Dahkki Greenberg, Richard N., Hay, Christine M., Stapleton, Jack T., Marbury, Thomas C., Wagner, Eva, Kreitmeir, Eva, Röesch, Siegfried, von Krempelhuber, Alfred, Young, Philip, Nichols, Richard, Meyer, Thomas P., Schmidt, Darja, Weigl, Josef, Virgin, Garth, Arndtz-Wiedemann, Nathaly, Chaplin, Paul

    Almmustuhtton 2016
    Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta
    Teaksta
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: